SRI-42127

N/A

Report date: 2023/04/20 09:43:31
NME

Base Information

Drug NameSRI-42127
Drug Alias NameSRI-42127
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionELAV-like protein 1 inhibitors
TargetsELAV-like protein 1
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSouthern Research Institute
China Registration ClassN/A

Develop Information

Active CompaniesSouthern Research Institute
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A